Title : Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner - Rose_2004_Brain.Res_1015_96 |
Author(s) : Rose M , Dudas B , Cornelli U , Hanin I |
Ref : Brain Research , 1015 :96 , 2004 |
Abstract : |
PubMedSearch : Rose_2004_Brain.Res_1015_96 |
PubMedID: 15223371 |
Title : Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats - Rose_2003_Neurobiol.Aging_24_481 |
Author(s) : Rose M , Dudas B , Cornelli U , Hanin I |
Ref : Neurobiology of Aging , 24 :481 , 2003 |
Abstract : |
PubMedSearch : Rose_2003_Neurobiol.Aging_24_481 |
PubMedID: 12600723 |
Title : Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain - Dudas_2002_Neurobiol.Aging_23_97 |
Author(s) : Dudas B , Cornelli U , Lee JM , Hejna MJ , Walzer M , Lorens SA , Mervis RF , Fareed J , Hanin I |
Ref : Neurobiology of Aging , 23 :97 , 2002 |
Abstract : |
PubMedSearch : Dudas_2002_Neurobiol.Aging_23_97 |
PubMedID: 11755024 |